Found: 14
Select item for more details and to access through your institution.
Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment.
- Published in:
- Clinical & Translational Medicine, 2019, v. 8, n. 1, p. 1, doi. 10.1186/s40169-019-0253-6
- By:
- Publication type:
- Article
Feasibility study of using high‐throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment.
- Published in:
- Clinical & Translational Medicine, 2019, v. 8, n. 1, p. 1, doi. 10.1186/s40169-019-0253-6
- By:
- Publication type:
- Article
HB-GAM (pleiotrophin) reverses inhibition of neural regeneration by the CNS extracellular matrix.
- Published in:
- Scientific Reports, 2016, p. 33916, doi. 10.1038/srep33916
- By:
- Publication type:
- Article
HMGB4 is expressed by neuronal cells and affects the expression of genes involved in neural differentiation.
- Published in:
- Scientific Reports, 2016, p. 32960, doi. 10.1038/srep32960
- By:
- Publication type:
- Article
Transmembrane Prostatic Acid Phosphatase (TMPAP) Interacts with Snapin and Deficient Mice Develop Prostate Adenocarcinoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0073072
- By:
- Publication type:
- Article
High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 10, p. 1365, doi. 10.3390/biom10101365
- By:
- Publication type:
- Article
Chemical, Physical and Biological Triggers of Evolutionary Conserved Bcl-xL-Mediated Apoptosis.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1694, doi. 10.3390/cancers12061694
- By:
- Publication type:
- Article
Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments.
- Published in:
- Briefings in Bioinformatics, 2022, v. 23, n. 1, p. 1, doi. 10.1093/bib/bbab350
- By:
- Publication type:
- Article
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 450, p. 1, doi. 10.1126/scitranslmed.aaq1093
- By:
- Publication type:
- Article
Identification and Tracking of Antiviral Drug Combinations.
- Published in:
- Viruses (1999-4915), 2020, v. 12, n. 10, p. 1178, doi. 10.3390/v12101178
- By:
- Publication type:
- Article
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF , neurturin, and artemin.
- Published in:
- Journal of Cell Biology, 2011, v. 192, n. 1, p. 153, doi. 10.1083/jcb.201009136
- By:
- Publication type:
- Article
N-syndecan deficiency impairs neural migration in brain.
- Published in:
- Journal of Cell Biology, 2006, v. 174, n. 4, p. 569, doi. 10.1083/jcb.200602043
- By:
- Publication type:
- Article
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep05193
- By:
- Publication type:
- Article